The generic drugs that Teva makes normally sell for materially less than the name-brand versions. While that leads to a steep decline in revenue for each company that originally created a now-generic ...

With its strengthening growth prospects, Teva may be the best healthcare stock to put $1,000 into right now. Here's why. On ...

Teva Pharmaceutical Industries Limited’s TEVA shares have risen 19.4% in the past month. A key driver of the stock price increase was its mixed second-quarter results announced on July 30. Teva’s ...

Teva Pharmaceutical Indus (NYSE: TEVA) underwent analysis by 13 analysts in the last quarter, revealing a spectrum of ...

Teva Pharmaceutical is a victim of its own success, Chief Executive Richard Francis said Wednesday as Teva stock plummeted on its light earnings outlook. For the year, the pharma behemoth expects to ...

Teva Pharmaceutical Industries Limited’s TEVA stock has risen 12.9% in a month. Teva’s stock mainly gained after it announced first-quarter 2025 results on May 7. Teva’s first-quarter results were ...

Teva Pharmaceutical Industries Limited’s TEVA shares have risen 21.6% in three months. Over the past few quarters, Teva has successfully launched several biosimilars and other high-value, complex ...

Teva's stock has risen 105% in two years, outperforming the S&P 500, but it is no longer a bargain at $17.50 per share. The company's focus on debt reduction has been successful, with net debt falling ...